{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:24:28Z","timestamp":1762957468466,"version":"3.41.2"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The Groupe d\u2019Etude sur les Affections Inflammatoires Digestives (GETAID) was founded in Paris in 1983 by Professor Robert Modigliani and colleagues. From the beginning, the aim of this international (France, Belgium, and Switzerland), multicenter, French-speaking group was to address clinical questions raised by patients or physicians in their daily practice or the inflammatory bowel disease community, by focusing on clinical research on treatments through randomized controlled trials, prospective cohorts, and cross-sectional studies, quantifying the severity of various facets of the disease when necessary for these studies. This very innovative approach has contributed to the advancement of knowledge in inflammatory bowel diseases by publishing more than 120 original articles in peer-reviewed journals throughout the GETAID\u2019s 40-year history, most of them in top publications in gastroenterology and hepatology journals. In this paper, we will see what GETAID\u2019s contribution has been over the last 4 decades and review the reasons for its success and forthcoming challenges.<\/jats:p>","DOI":"10.1093\/ecco-jcc\/jjae122","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T12:17:52Z","timestamp":1724933872000},"source":"Crossref","is-referenced-by-count":2,"title":["The Groupe d\u2019Etude sur les Affections Inflammatoires Digestives\u00a0(GETAID): 40 Years of a Family Story in Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"19","author":[{"given":"David","family":"Laharie","sequence":"first","affiliation":[{"name":"CHU de Bordeaux, Centre Medico-chirurgical Magellan, H\u00f4pital Haut-L\u00e9v\u00eaque, Gastroenterology Department, Universit\u00e9 de Bordeaux, INSERM CIC 1401 , Bordeaux ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9845-6572","authenticated-orcid":false,"given":"Lucine","family":"Vuitton","sequence":"additional","affiliation":[{"name":"CHU de Besan\u00e7on, Service de Gastroent\u00e9rologie, UMR Inserm Right, Universit\u00e9 de Franche-Comt\u00e9 , Besan\u00e7on ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Bourreille","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, CHU de Nantes, H\u00f4tel-Dieu, H\u00e9pato-Gastroent\u00e9rologie, Institut des Maladies de l\u2019Appareil Digestif, CIC Inserm 1413 , Nantes ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoram","family":"Bouhnik","sequence":"additional","affiliation":[{"name":"Paris IBD Center, Groupe Hospitalier Priv\u00e9 Ambroise Par\u00e9 \u2013 Hartmann , Neuilly sur Seine ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fr\u00e9d\u00e9ric","family":"Colombel","sequence":"additional","affiliation":[{"name":"The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai , New York, NY ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Louis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital CHU of Li\u00e8ge , Li\u00e8ge ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2337-2902","authenticated-orcid":false,"given":"Mathurin","family":"Fumery","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Amiens University Hospital, Amiens ,","place":["France"]},{"name":"PeriTox, Universit\u00e9 de Picardie , Amiens ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Mailhat","sequence":"additional","affiliation":[{"name":"GETAID , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves","family":"Mary","sequence":"additional","affiliation":[{"name":"UMR-S-1153 Inserm, Equipe ECSTRRA, Denis Diderot \u2013 Paris 7 University, H\u00f4pital Saint-Louis , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Brabois Hospital, Nancy University , Nancy les Vandoeuvre-l\u00e8s-Nancy ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"2025021912241815800_CIT0001","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/gut.26.2.146","article-title":"Prognosis in Crohn\u2019s disease\u2014based on results from a regional patient group from the county of Copenhagen","volume":"26","author":"Binder","year":"1985","journal-title":"Gut"},{"key":"2025021912241815800_CIT0002","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/gut.2010.234617","article-title":"Surgery for adult Crohn\u2019s disease: what is the actual risk","volume":"60","author":"Bouguen","year":"2011","journal-title":"Gut"},{"key":"2025021912241815800_CIT0003","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/gutjnl-2013-305607","article-title":"Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011","volume":"63","author":"Rungoe","year":"2014","journal-title":"Gut"},{"key":"2025021912241815800_CIT0004","first-page":"683","article-title":"Effect of levamisole on the prevention of developmental flare-ups in quiescent Crohn\u2019s disease: a prospective multicenter controlled trial in 155 patients","volume":"7","author":"Modigliani","year":"1983","journal-title":"Gastroenterol Clin Biol"},{"key":"2025021912241815800_CIT0005","first-page":"411","article-title":"Un mod\u00e8le d\u2019excellence scientifique fran\u00e7aise et d\u2019amiti\u00e9: le GETAID (Groupe d\u2019Etude Th\u00e9rapeutique des Affections Inflammatoires Digestives). En hommage \u00e0 Robert Modigliani","volume":"28","author":"Cortot","year":"2021","journal-title":"H\u00e9pato-Gastro Oncol Digest"},{"key":"2025021912241815800_CIT0006","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/BF01296663","article-title":"Reproducibility of colonoscopic findings in Crohn\u2019s disease: a prospective multicenter study of interobserver variation. Groupe d\u2019Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)","volume":"32","author":"Modigliani","year":"1987","journal-title":"Dig Dis Sci"},{"key":"2025021912241815800_CIT0007","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/gut.30.7.983","article-title":"Development and validation of an endoscopic index of the severity for Crohn\u2019s disease: a prospective multicentre study. Groupe d\u2019Etudes Th\u00e9rapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)","volume":"30","author":"Mary","year":"1989","journal-title":"Gut"},{"key":"2025021912241815800_CIT0008","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1053\/j.gastro.2005.03.031","article-title":"A randomized, double-blind, controlled withdrawal trial in Crohn\u2019s disease patients in long-term remission on azathioprine","volume":"128","author":"L\u00e9mann","year":"2005","journal-title":"Gastroenterology"},{"key":"2025021912241815800_CIT0009","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cgh.2008.08.028","article-title":"Azathioprine withdrawal in patients with Crohn\u2019s disease maintained on prolonged remission: a high risk of relapse","volume":"7","author":"Treton","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025021912241815800_CIT0010","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1053\/j.gastro.2006.02.014","article-title":"Infliximab plus azathioprine for steroid-dependent Crohn\u2019s disease patients: a randomized placebo-controlled trial","volume":"130","author":"Lemann","year":"2006","journal-title":"Gastroenterology"},{"key":"2025021912241815800_CIT0011","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(12)61084-8","article-title":"Ciclosporine versus infliximab in acute severe colitis refractory to intravenous steroids: a randomized study","volume":"380","author":"Laharie","year":"2012","journal-title":"Lancet"},{"key":"2025021912241815800_CIT0012","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gutjnl-2016-313060","article-title":"Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab","volume":"67","author":"Laharie","year":"2018","journal-title":"Gut"},{"key":"2025021912241815800_CIT0013","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.gastro.2011.09.034","article-title":"Maintenance of remission among patients with Crohn\u2019s disease on anti-metabolite therapy after infliximab therapy is stopped","volume":"142","author":"Louis","year":"2012","journal-title":"Gastroenterology"},{"key":"2025021912241815800_CIT0014","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S2468-1253(22)00385-5","article-title":"Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn\u2019s disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial","volume":"8","author":"Louis","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025021912241815800_CIT0015","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1053\/j.gastro.2013.04.048","article-title":"Early administration of azathioprine vs conventional management of Crohn\u2019s disease: a randomized controlled trial","volume":"145","author":"Cosnes","year":"2013","journal-title":"Gastroenterology"},{"key":"2025021912241815800_CIT0016","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/gutjnl-2016-312581","article-title":"Efficacy of adalimumab in patients with Crohn\u2019s disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study","volume":"67","author":"Bouhnik","year":"2018","journal-title":"Gut"},{"key":"2025021912241815800_CIT0017","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/j.cgh.2023.01.013","article-title":"Adalimumab in biologic-naive patients with Crohn\u2019s disease after resolution of an intra-abdominal abscess: a prospective study from the GETAID","volume":"21","author":"Bouhnik","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025021912241815800_CIT0018","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0016-5085(90)90002-I","article-title":"Clinical, biological, and endoscopic picture of attacks of Crohn\u2019s disease. Evolution on prednisolone. Groupe d\u2019Etude Th\u00e9rapeutique des Affections Inflammatoires Digestives","volume":"98","author":"Modigliani","year":"1990","journal-title":"Gastroenterology"},{"key":"2025021912241815800_CIT0019","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/0016-5085(92)91725-J","article-title":"Endoscopic monitoring of Crohn\u2019s disease treatment: a prospective, randomized clinical trial. The Groupe d\u2019Etudes Therapeutiques des Affections Inflammatoires Digestives","volume":"102","author":"Landi","year":"1992","journal-title":"Gastroenterology"},{"key":"2025021912241815800_CIT0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/gut.35.2.231","article-title":"Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn\u2019s disease. A prospective multicentre study of 121 cases","volume":"35","author":"Cellier","year":"1994","journal-title":"Gut"},{"key":"2025021912241815800_CIT0021","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cgh.2022.09.018","article-title":"I-CARE, a European prospective cohort study assessing safety and effectiveness of biologics in inflammatory bowel disease","volume":"21","author":"Peyrin-Biroulet","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025021912241815800_CIT0022","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1053\/j.gastro.2018.01.004","article-title":"Increasing infliximab dose based on symptoms, biomarkers, and serum drug concentrations does not increase clinical, endoscopic, or corticosteroid-free remission in patients with active luminal Crohn\u2019s disease","volume":"154","author":"D\u2019Haens","year":"2018","journal-title":"Gastroenterology"},{"key":"2025021912241815800_CIT0023","first-page":"OP211","article-title":"Infliximab plus azathioprine and quick steroids discontinuation versus azathioprine plus steroids in patients with acute severe ulcerative colitis responding to intravenous steroids: a parallel, open-label randomized controlled trial","volume-title":"UEGW","author":"Amiot","year":"2023"},{"key":"2025021912241815800_CIT0024","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/j.gastro.2015.10.050","article-title":"Methotrexate is not superior to placebo for inducing steroid-free remission, but induces steroid-free clinical remission in a larger proportion of patients with ulcerative colitis","volume":"150","author":"Carbonnel","year":"2016","journal-title":"Gastroenterology"},{"key":"2025021912241815800_CIT0025","first-page":"441","article-title":"Recommandations de pratique pour le diagnostic et la prise en charge de la rectocolite h\u00e9morragique","volume":"29","author":"Amiot","year":"2022","journal-title":"H\u00e9pato-Gastro Oncol Digest"},{"key":"2025021912241815800_CIT0026","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0016-5085(93)90411-5","article-title":"Oral mesalamine (Pentasa) as maintenance treatment in Crohn\u2019s disease: a multicenter placebo-controlled study. The Groupe d\u2019Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID)","volume":"104","author":"Gendre","year":"1993","journal-title":"Gastroenterology"},{"key":"2025021912241815800_CIT0027","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0016-5085(94)90159-7","article-title":"Treatment of Crohn\u2019s disease by lymphocyte apheresis: a randomized controlled trial. Groupe d\u2019Etudes Th\u00e9rapeutiques des Affections Inflammatoires Digestives","volume":"107","author":"Lerebours","year":"1994","journal-title":"Gastroenterology"},{"key":"2025021912241815800_CIT0028","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00042737-199603000-00008","article-title":"Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn\u2019s disease. Groupe d\u2019Etudes Th\u00e9rapeutiques des Affections Inflammatoires Digestives (GETAID)","volume":"8","author":"Florent","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025021912241815800_CIT0029","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1053\/gast.1996.v110.pm8608877","article-title":"Mesalamine in Crohn\u2019s disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d\u2019Etudes Th\u00e9rapeutiques des Affections Inflammatoires Digestives","volume":"110","author":"Modigliani","year":"1996","journal-title":"Gastroenterology"},{"key":"2025021912241815800_CIT0030","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1572-0241.1999.935_q.x","article-title":"A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn\u2019s disease. Groupe d\u2019Etudes Th\u00e9rapeutiques des Affections Inflammatoires Digestives (GETAID)","volume":"94","author":"Colombel","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"2025021912241815800_CIT0031","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1365-2036.2002.01247.x","article-title":"Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride","volume":"16","author":"Abitbol","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"2025021912241815800_CIT0032","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/gut.2005.076604","article-title":"Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn\u2019s disease: a randomised, double blind, placebo controlled GETAID trial","volume":"55","author":"Marteau","year":"2006","journal-title":"Gut"},{"key":"2025021912241815800_CIT0033","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1053\/j.gastro.2010.02.013","article-title":"Fibrin glue is effective healing perianal fistulas in patients with Crohn\u2019s disease","volume":"138","author":"Grimaud","year":"2010","journal-title":"Gastroenterology"},{"key":"2025021912241815800_CIT0034","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/gutjnl-2012-302262","article-title":"Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn\u2019s disease following treatment with certolizumab pegol","volume":"62","author":"H\u00e9buterne","year":"2013","journal-title":"Gut"},{"key":"2025021912241815800_CIT0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ecco-jcc\/jjv162","article-title":"Fistula plug in fistulising ano-perineal Crohn\u2019s disease: a randomised controlled trial","volume":"10","author":"Sen\u00e9joux","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2025021912241815800_CIT0036","first-page":"616","article-title":"Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy","volume":"67","author":"Moussata","year":"2018","journal-title":"Gut"},{"key":"2025021912241815800_CIT0037","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/ecco-jcc\/jjaa195","article-title":"Impact of an education programme on IBD patients\u2019 skills: results of a randomised controlled multicentre study [ECIPE]","volume":"15","author":"Moreau","year":"2021","journal-title":"J Crohns Colitis"},{"key":"2025021912241815800_CIT0038","first-page":"MP010","article-title":"Changing the course of Crohn\u2019s disease with an early use of adalimumab: the CURE study from the GETAID","volume-title":"UEGW","author":"Caron","year":"2023"},{"key":"2025021912241815800_CIT0039","first-page":"P679","article-title":"Anti-TNF de-escalation following a treat-to-target strategy with golimumab therapy intensification to reach continuous clinical response in ulcerative colitis: the In-Target GETAID trial","volume-title":"ECCO","author":"Vuitton","year":"2024"},{"key":"2025021912241815800_CIT0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(96)90402-X","article-title":"Long-term follow-up of patients with Crohn\u2019s disease treated with azathioprine or 6-mercaptopurine","volume":"347","author":"Bouhnik","year":"1996","journal-title":"Lancet"},{"key":"2025021912241815800_CIT0041","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"2025021912241815800_CIT0042","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/gutjnl-2011-300486","article-title":"Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)","volume":"61","author":"Travis","year":"2012","journal-title":"Gut"},{"key":"2025021912241815800_CIT0043","doi-asserted-by":"crossref","first-page":"otac004","DOI":"10.1093\/crocol\/otac004","article-title":"Development of a new index to assess small bowel inflammation severity in Crohn\u2019s disease using magnetic resonance enterography","volume":"4","author":"Bouhnik","year":"2022","journal-title":"Crohns Colitis 360"},{"key":"2025021912241815800_CIT0044","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2014.09.015","article-title":"Development of the Lemann index to assess digestive tract damage in patients with Crohn\u2019s disease","volume":"148","author":"Pariente","year":"2015","journal-title":"Gastroenterology"},{"key":"2025021912241815800_CIT0045","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/379821a0","article-title":"Mapping of a susceptibility locus for Crohn\u2019s disease on chromosome 16","volume":"379","author":"Hugot","year":"1996","journal-title":"Nature"},{"key":"2025021912241815800_CIT0046","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/SLA.0000000000002017","article-title":"Anti-TNF therapy is associated with an increased risk of postoperative morbidity after surgery for ileocolonic Crohn disease: results of a prospective nationwide cohort","volume":"267","author":"Brouquet","year":"2018","journal-title":"Ann Surg"},{"key":"2025021912241815800_CIT0047","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/MPG.0000000000003758","article-title":"Ustekinumab use in pediatric inflammatory bowel disease: a French multicenter study from the Pediatric GETAID","volume":"76","author":"Koudsi","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025021912241815800_CIT0048","doi-asserted-by":"crossref","first-page":"134","DOI":"10.14309\/ajg.0000000000000834","article-title":"Location but not severity of endoscopic lesions influences endoscopic remission rates in Crohn\u2019s disease: a post hoc analysis of TAILORIX","volume":"116","author":"Rivi\u00e8re","year":"2021","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjae122\/60587932\/jjae122.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/19\/2\/jjae122\/60587932\/jjae122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/19\/2\/jjae122\/60587932\/jjae122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T12:24:38Z","timestamp":1739967878000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/doi\/10.1093\/ecco-jcc\/jjae122\/7745006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae122","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"type":"print","value":"1873-9946"},{"type":"electronic","value":"1876-4479"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,8,29]]},"article-number":"jjae122"}}